SGMO priced its public offering of 6.7M shares at a price of $7.70 per share. Read more…
SGMO’s experimental gene/cell therapy was used safely in 6 patients infected with HIV in the first trial Read more…
Founder and Director of Research, Henry McCusker enters his tenth (10) year at Scimitar Equity with past experience in sell-side analysis, buy-side management, corporate management and due diligence.
I started this blog to add commentary, update news flow and insightful opinions that are intelligent, fit to print and SEC compliant.